cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pieris Pharmaceuticals Inc
20 own
32 watching
Current Price
$0
$-0.06
(-3.77%)
logo-pirs
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
118.31M
52-Week High
52-Week High
3.68
52-Week Low
52-Week Low
0.8464
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization118.31M
icon52-Week High3.68
icon52-Week Low0.8464
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio--
What does the Pieris Pharmaceuticals Inc do?
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company primarily focuses on the development of three drug candidates, including PRS-080 designed to target hepcidin for the treatment of functional iron deficiency in anemic patients with chronic kidney disease or in end-stage renal disease patients requiring dialysis; PRS-060, a drug candidate that binds to the IL-4RA receptor alpha-chain, which is used for the treatment of asthma and other inflammatory diseases; and PRS-343, a bispecific protein for oncology diseases. The company has collaboration agreements with Allergan, Inc.; Daiichi Sankyo Company Limited; Sanofi Group; Cadila Healthcare Limited (Zydus Cadila); Strides Arcolab Limited; and F.HoffmannLa Roche Ltd. It also has a strategic alliance with Servier Forge for the co-development of immuno-oncology. Pieris Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Read More
How much money does Pieris Pharmaceuticals Inc make?
News & Events about Pieris Pharmaceuticals Inc.
Accesswire
21days ago
BOSTON, MA / ACCESSWIRE / January 10, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other conditions, today announced that...
Accesswire
2 months ago
BOSTON, MA / ACCESSWIRE / November 23, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced...
Accesswire
2 months ago
BOSTON, MA / ACCESSWIRE / November 9, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that...
Accesswire
3 months ago
BOSTON, MA / ACCESSWIRE / November 1, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced...
Zolmax
7 months ago
Woodline Partners LP bought a new stake in shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS Get Rating) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 2,463,641 shares of the biotechnology companys stock, valued at approximately $9,313,000. Other large investors ...
Frequently Asked Questions
Frequently Asked Questions
What is Pieris Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Pieris Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Pieris Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Pieris Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pieris Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Pieris Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Pieris Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pieris Pharmaceuticals Inc?
plus_minus_icon
What percentage is Pieris Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pieris Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.06
(-3.77%)
logo-pirs
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00